Dorr RT - Search Results

1

In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.

Alberts DS, Dorr RT, Wunz TP, Remers WA, Einspahr J, Liu R, Salmon SE. Alberts DS, et al. Among authors: dorr rt. Anticancer Drugs. 1991 Feb;2(1):69-77. doi: 10.1097/00001813-199102000-00010. Anticancer Drugs. 1991. PMID: 1958855

2

A phase I/II trial of paclitaxel for non-Hodgkin's lymphoma followed by paclitaxel plus quinine in drug-resistant disease.

Miller TP, Chase EM, Dorr R, Dalton WS, Lam KS, Salmon SE. Miller TP, et al. Anticancer Drugs. 1998 Feb;9(2):135-40. doi: 10.1097/00001813-199802000-00004. Anticancer Drugs. 1998. PMID: 9510499 Clinical Trial.

3

Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration.

Bellamy WT, Dorr RT, Dalton WS, Alberts DS. Bellamy WT, et al. Among authors: dorr rt. Cancer Res. 1988 Nov 15;48(22):6360-4. Cancer Res. 1988. PMID: 3180055

4

Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationship.

Sami SM, Dorr RT, Sólyom AM, Alberts DS, Remers WA. Sami SM, et al. Among authors: dorr rt. J Med Chem. 1995 Mar 17;38(6):983-93. doi: 10.1021/jm00006a018. J Med Chem. 1995. PMID: 7699715

5

Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.

Shipp NG, Dorr RT, Alberts DS, Dawson BV, Hendrix M. Shipp NG, et al. Among authors: dorr rt. Cancer Res. 1993 Feb 1;53(3):550-6. Cancer Res. 1993. PMID: 8425187

6

2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agent.

Sami SM, Dorr RT, Alberts DS, Remers WA. Sami SM, et al. Among authors: dorr rt. J Med Chem. 1993 Mar 19;36(6):765-70. doi: 10.1021/jm00058a014. J Med Chem. 1993. PMID: 8459403

7

6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships.

Sami SM, Dorr RT, Sòlyom AM, Alberts DS, Iyengar BS, Remers WA. Sami SM, et al. Among authors: dorr rt. J Med Chem. 1996 Apr 12;39(8):1609-18. doi: 10.1021/jm950742g. J Med Chem. 1996. PMID: 8648600

8

Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.

Dorr RT, Dvorakova K, Snead K, Alberts DS, Salmon SE, Pettit GR. Dorr RT, et al. Invest New Drugs. 1996;14(2):131-7. doi: 10.1007/BF00210783. Invest New Drugs. 1996. PMID: 8913833

9

2-[2'-(Dimethylamino)ethyl]-1,2-dihydro- 3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity, and quantitative structure-activity relationships.

Sami SM, Dorr RT, Alberts DS, Sólyom AM, Remers WA. Sami SM, et al. Among authors: dorr rt. J Med Chem. 1996 Dec 6;39(25):4978-87. doi: 10.1021/jm960623g. J Med Chem. 1996. PMID: 8960558

10

1,4-disubstituted anthracene antitumor agents.

Iyengar BS, Dorr RT, Alberts DS, Sólyom AM, Krutzsch M, Remers WA. Iyengar BS, et al. Among authors: dorr rt. J Med Chem. 1997 Nov 7;40(23):3734-8. doi: 10.1021/jm970308+. J Med Chem. 1997. PMID: 9371238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters